About |
Crozet BioPharma, LLC, headquartered in Devens, Massachusetts, is a biotechnology company developing medical countermeasures for infectious disease and cancer. Crozet’s team includes individuals with deep industry experience demonstrated by their collective track record and experience developing ten licensed vaccines. While at NewLink Genetics, the Crozet team enabled transfer of the technology to Merck, obtained over $100 million in funding and supported Merck’s advanced development of the rVSV-EBOV Ebola vaccine. Most recently, Crozet has partnered with Public Health Vaccines, LLC to support delivery of PHV’s rVSV-Marburg and rVSV-Nipah vaccine candidates.
For more information, visit the company’s website at www.crozetbiopharma.com.